Melanoma & biomarkers of immunoresponsiveness - sprookjes - yvandenbroek - TriplyDB

Melanoma & biomarkers of immunoresponsiveness

Melanoma & biomarkers of immunoresponsiveness

http://www.wikidata.org/entity/Q58234468

about

Melanoma & biomarkers of immunoresponsiveness

http://www.wikidata.org/entity/Q58234468

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2012

@uk

name

Melanoma & biomarkers of immunoresponsiveness

@en

Melanoma & biomarkers of immunoresponsiveness

@nl

type

label

Melanoma & biomarkers of immunoresponsiveness

@en

Melanoma & biomarkers of immunoresponsiveness

@nl

prefLabel

Melanoma & biomarkers of immunoresponsiveness

@en

Melanoma & biomarkers of immunoresponsiveness

@nl

P1476

Q58234468-63DD3DB6-6454-4D16-A388-BCE2E120F5C0

P2093

Q58234468-015C3DD1-F440-4DAE-B3F5-811764304A6C

Q58234468-704FC51C-0614-4607-BB31-AED13D18D57F

Q58234468-CD4C6B37-1C49-41F5-8353-A8AD6DA4D608

Q58234468-D6D53AF2-4C83-43A9-8047-FE646E3DA37A

P2860

Q58234468-0E4E8599-C5C0-4D79-8336-896DFE0C6B4B

Q58234468-0F857A7B-BC85-4613-BD3D-389F82F2ECB9

Q58234468-13BD9A6D-1A31-4318-854D-DF623BD09BCB

Q58234468-14A3B0A0-7981-491E-845E-5C4919C81E6C

Q58234468-178E1F03-4C11-4B5C-906B-E49055CF34DC

Q58234468-18E3AA36-1069-4329-B712-67773EFA6027

Q58234468-19D1C619-FD0C-4B22-AF94-BC53DA0BA187

Q58234468-1D580BA4-9DFE-4CD1-8B67-8D1565CEACC6

Q58234468-279C01AF-246E-4839-BCAC-DD90C73549A9

Q58234468-287ABC58-661D-4645-9020-7B3246CC12D4

P304

Q58234468-6B9D053E-B011-48B1-83C0-6AF37E52FA6E

P31

Q58234468-2C11455B-955E-4F8E-AFBD-904391EB2865

P356

Q58234468-DD6277FE-5F0E-47AD-9DB4-CB4FA3E9E7A4

P577

Q58234468-C13266FB-B6DD-4823-BE4B-C4D03563C5CD

P356

P1476

Melanoma & biomarkers of immunoresponsiveness

@en

P2093

Bedognetti Davide

http://www.w3.org/2001/XMLSchema#string

Marincola Francesco M

http://www.w3.org/2001/XMLSchema#string

Sertoli Mario Roberto

http://www.w3.org/2001/XMLSchema#string

Wang Ena

http://www.w3.org/2001/XMLSchema#string

P2860

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Forecasting the cytokine storm following systemic interleukin (IL)-2 administration

An immunologic portrait of cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology

P304

120-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/EBO.11.260

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime